175 results
8-K
EX-99.1
h5ttq
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
EX-99.2
ocedkd
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-99.1
3s5vt1zsmhjhkd5d
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-10.1
m56v871 fxl
5 Feb 24
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
8:09am
8-K
EX-2.1
4nf9zthneat 2a
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
EX-99.1
wsxy3t2 tzsj
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
EX-99.1
ct35f 4ou
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K/A
EX-99.1
je49x
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K
EX-99.1
mj848glu3 xub
27 Oct 23
Regulation FD Disclosure
4:19pm
424B5
opjshh7wfbi2jl3ne4
12 Sep 23
Prospectus supplement for primary offering
6:04am